Home The Word Brain My Amedeo FAQ Privacy About


Amedeo Chinese

For Medical Students & Physicians

A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever.

Download the free PDF: Amedeo Chinese PDF

  Drug Resistance

  Free Subscription


10.08.2026

1 Am J Trop Med Hyg
13 Antimicrob Agents Chemother
1 Clin Infect Dis
7 Int J Antimicrob Agents
5 J Antimicrob Chemother
1 J Infect Chemother
4 J Infect Dis
1 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Trop Med Hyg

  1. NZABANTERURA I, Oyebadejo SA, Mbarushimana D, Musabyumuremyi C, et al
    Carbapenem-Resistant Klebsiella pneumoniae in Clinical Specimens at the University Teaching Hospital of Butare, Rwanda: Antimicrobial Resistance Profiles and Carbapenemase Genes.
    Am J Trop Med Hyg. 2026 Aug 6:tpmd260248. doi: 10.4269/ajtmh.26-0248.
    PubMed         Abstract available


    Antimicrob Agents Chemother

  2. XIE O, Tan A, Nguyen TB, Hayes AJ, et al
    Penicillin-resistant Streptococcus dysgalactiae subsp. equisimilis and the association with penicillin-binding protein mutations: a population genotypic and phenotypic study.
    Antimicrob Agents Chemother. 2026 Aug 3:e0013726. doi: 10.1128/aac.00137.
    PubMed         Abstract available

  3. CHENG S, Clancy CJ, Fleres G, Badrane H, et al
    Emergence of mutH(V76G) in carbapenem-resistant Klebsiella pneumoniae disrupts DNA mismatch repair and results in a hypermutator phenotype.
    Antimicrob Agents Chemother. 2026 Aug 5:e0018926. doi: 10.1128/aac.00189.
    PubMed         Abstract available

  4. ZHU Z, Long T, Wang B, Ding W, et al
    Genome-wide transposon screening uncovers phage resistance mechanisms and bidirectional effects on antibiotic susceptibility in carbapenem-resistant Klebsiella pneumoniae.
    Antimicrob Agents Chemother. 2026 Aug 5:e0050626. doi: 10.1128/aac.00506.
    PubMed         Abstract available

  5. KAPLE CE, Redmond SN, Cadnum JL, Hausman B, et al
    Clinical failure of an extended-pulsed fidaxomicin regimen associated with emergence of a Clostridioides difficile isolate with reduced fidaxomicin susceptibility in an elderly man.
    Antimicrob Agents Chemother. 2026;70:e0013026.
    PubMed         Abstract available

  6. FERNANDEZ MA, Gomez Gomez MJ, Cisneros JM, Lepe JA, et al
    Characterization of BAS-1, a novel class A beta-lactamase encoded in Bacteroides thetaiotaomicron.
    Antimicrob Agents Chemother. 2026;70:e0039126.
    PubMed         Abstract available

  7. SASTRE-FEMENIA MA, Gomis-Font MA, Fernandez-Munoz A, Salazar-Londono D, et al
    Characterizing the V516M penicillin-binding protein 2 (PBP2) mutation causing zidebactam resistance in Pseudomonas aeruginosa.
    Antimicrob Agents Chemother. 2026;70:e0034626.
    PubMed         Abstract available

  8. ROME KJ, Terlecky AJ, Yen KK, Long T, et al
    Intrinsic resistance networks shape cefiderocol susceptibility in ST258 Klebsiella pneumoniae.
    Antimicrob Agents Chemother. 2026;70:e0019726.
    PubMed         Abstract available

  9. CORRAL J, Perez-Varela M, Gaona M, Campoy S, et al
    A newly identified homologous SxtPR efflux system contributes to sulfamethoxazole/trimethoprim susceptibility and pathogenesis in Klebsiella pneumoniae.
    Antimicrob Agents Chemother. 2026;70:e0164425.
    PubMed         Abstract available

  10. SCHUMANN A, O'Keefe IP, Ernst RK, Wiedmann M, et al
    Acquired mutations in transcriptional regulator hns and lipopolysaccharide biosynthesis and modification genes impact colistin resistance and fitness of mcr-carrying E. coli.
    Antimicrob Agents Chemother. 2026;70:e0045726.
    PubMed         Abstract available

  11. MAEDA A, Sato T, Fukuda A, Okubo T, et al
    A community-based One Health approach to the pandemic dynamics of Escherichia coli ST131.
    Antimicrob Agents Chemother. 2026;70:e0000726.
    PubMed         Abstract available

  12. HERNANDEZ-GARCIA M, Perez-Viso B, Nieto-Torres M, Garcia-Castillo M, et al
    Addressing therapeutic options for KPC-3-producing ST307-Klebsiella pneumoniae: insights from in vitro evolution and mutant prevention strategies.
    Antimicrob Agents Chemother. 2026;70:e0048826.
    PubMed         Abstract available

  13. KAPOOR A, Ghosh AK, Forman M, Skaist A, et al
    A novel inhibitor of human cytomegalovirus acts through a specific antiviral mechanism that involves the helicase-primase complex.
    Antimicrob Agents Chemother. 2026 Jul 13:e0197725. doi: 10.1128/aac.01977.
    PubMed         Abstract available

  14. HU E-W, Kuo P-C, Li L-H, Yen C-S, et al
    NagX, a periplasmic beta-N-acetylglucosaminidase, contributes to NagZ-independent beta-lactamase expression in Stenotrophomonas maltophilia.
    Antimicrob Agents Chemother. 2026;70:e0024326.
    PubMed         Abstract available


    Clin Infect Dis

  15. TAMMA PD, Bonomo RA, Heil EL, Justo JA, et al
    Infectious Diseases Society of America 2026 Guidance on the Treatment of Antimicrobial-Resistant Gram-Negative Infections.
    Clin Infect Dis. 2026 Aug 8:ciag481. doi: 10.1093.
    PubMed         Abstract available


    Int J Antimicrob Agents

  16. LI J
    Comment on "Burden and global distribution of antimicrobial resistance in non-bloodstream infections among adults with cirrhosis: a systematic review and proportional meta-analysis".
    Int J Antimicrob Agents. 2026 Aug 5:107951.
    PubMed        

  17. ZHOU M, Zhou Y, Xiang C, Liu Y, et al
    Early prediction of carbapenem resistance phenotype in ICU-acquired Acinetobacter baumannii infection before susceptibility reporting: a temporally validated study.
    Int J Antimicrob Agents. 2026 Aug 8:107957.
    PubMed         Abstract available

  18. RODRIGUEZ-RODRIGUEZ M, Alanis-Dominguez E, Casimiro-Soriguer CS, Ortiz de la Rosa JM, et al
    Essential role of the leucine-293 for the AmpC beta-lactamase in the resistance to cefepime, cefiderocol, and new beta-lactams/beta-lactamase inhibitor combinations in Enterobacter hormaechei.
    Int J Antimicrob Agents. 2026;67:107848.
    PubMed         Abstract available

  19. HUANG J, Lu X, Xiang J, Wang Q, et al
    Co-occurrence of carbapenem and tigecycline resistance genes in ST1545 Klebsiella pneumoniae clinical isolates from China.
    Int J Antimicrob Agents. 2026;67:107856.
    PubMed         Abstract available

  20. ZHU B, Wang D, Zhang C, Yang Y, et al
    Characterization of a novel mosaic-like mtr operon and inter-regional transmission of dual-resistant Neisseria gonorrhoeae ST7363 sub-lineage in China.
    Int J Antimicrob Agents. 2026;67:107858.
    PubMed         Abstract available

  21. FAN X, Wang N, Chen X, Tan C, et al
    Droplet digital PCR assay for simultaneous detection of the ERG11 mutation and copy number variation associated with azole resistance in Candida tropicalis.
    Int J Antimicrob Agents. 2026;67:107847.
    PubMed         Abstract available

  22. YANG M, Liu Y, Xu K, Wang P, et al
    Antifungal and immunomodulatory activities of dihydroartemisinin-loaded chitosan nanoparticles against fluconazole?resistant Candida tropicalis.
    Int J Antimicrob Agents. 2026;67:107875.
    PubMed         Abstract available


    J Antimicrob Chemother

  23. DINATA R, Baindara P, Chakraborty S, Mondal S, et al
    Mutation-driven alterations in the AcrB efflux pump modulate antibiotic resistance in Klebsiella pneumoniae.
    J Antimicrob Chemother. 2026;81:dkag270.
    PubMed         Abstract available

  24. GONCALVES O, Cote JP
    Genome-wide network of antibiotic susceptibility in Pseudomonas aeruginosa.
    J Antimicrob Chemother. 2026;81:dkag272.
    PubMed         Abstract available

  25. PAOPANG P, Sangprasert P, Golparian D, Girdthep N, et al
    Antimicrobial resistance in Neisseria gonorrhoeae isolates at the Bangrak STIs Center, Bangkok, Thailand and WGS of antimicrobial-resistant isolates, 2018-23.
    J Antimicrob Chemother. 2026;81:dkag260.
    PubMed         Abstract available

  26. SHAH S, Clarke LG, Kline EG, Marini RV, et al
    Clinical characteristics and outcomes of patients with bacteraemia caused by non-carbapenemase-producing, carbapenem-resistant Enterobacterales.
    J Antimicrob Chemother. 2026;81:dkag267.
    PubMed         Abstract available

  27. PORTAIS A, Lastere S, Boutolleau D
    Treatment of acyclovir-resistant varicella-zoster virus keratitis with amenamevir in an immunocompromised patient.
    J Antimicrob Chemother. 2026;81:dkag275.
    PubMed        


    J Infect Chemother

  28. IWASE S, Muto T, Yamamoto T, Ozeki S, et al
    Macrolide resistance rate and antimicrobial selection in pediatric Mycoplasma pneumoniae infection during 2024.
    J Infect Chemother. 2026 Aug 6:103048. doi: 10.1016/j.jiac.2026.103048.
    PubMed         Abstract available


    J Infect Dis

  29. MUKHERJEE A, Blomqvist SOP, Helekal D, Das AA, et al
    Genetic Background Modulates Zoliflodacin and Gepotidacin Cross-Resistance and Fitness in Neisseria gonorrhoeae.
    J Infect Dis. 2026;234:e131-e140.
    PubMed         Abstract available

  30. KROUSTALI V, Pournaras S, Meletiadis J
    Can fluconazole be used to treat non-resistant Candida (Candidozyma) auris infections? Preclinical PK/PD data from a Galleria mellonella infection model.
    J Infect Dis. 2026 Mar 20:jiag182. doi: 10.1093.
    PubMed         Abstract available

  31. OTERINO-MOREIRA I, Perez-Encinas M, Lorenzo-Martinez S, Candel-Gonzalez FJ, et al
    Hospitalization Costs Attributable to Antimicrobial Resistance in Spain: A Nationwide Cohort Study.
    J Infect Dis. 2026 Aug 7:jiag405. doi: 10.1093.
    PubMed         Abstract available

  32. GONTJES KJ, Kelly BJ, Cressman L, Jaskowiak-Barr A, et al
    Changing molecular epidemiology and resistance patterns of carbapenem-resistant Klebsiella pneumoniae in California long-term acute care hospitals.
    J Infect Dis. 2026 Aug 7:jiag406. doi: 10.1093.
    PubMed         Abstract available


    PLoS One

  33. JAHAN R, Fahim NAI, Hasan MAE, Rana ML, et al
    Fresh fruit surface: A potential source for multidrug-resistant biofilm-forming Enterococcus faecalis having potential public health significance.
    PLoS One. 2026;21:e0355410.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Drug Resistance is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum